508.8K XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Douglas J Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 90,000 | 90,000 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 900,000 | 900,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 290,000 | 290,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 10 Jan 2025 | 30,000 | 83,141 (0%) | 0% | 0.3 | 8,400 | Common Stock |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Douglas J Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 90,000 | 90,000 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 900,000 | 900,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 290,000 | 290,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Darrell Shane Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 260,000 | 260,000 | - | - | Stock option (right to buy) | |
| Andrei Shustov | Senior Vice President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 260,000 | 260,000 | - | - | Stock option (right to buy) | |
| Andrei Shustov | Senior Vice President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 47,856 | 55,037 (0%) | 0% | 0 | Common Stock | |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 47,650 | - | - | Stock option (right to buy) | |
| Douglas J Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 37,500 | 71,925 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 47,887 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 47,885 | - | - | Stock option (right to buy) | |
| Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 40,600 | - | - | Stock option (right to buy) | |
| Shane Darrell Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Longcor Jarrod | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 144,000 | 144,000 | - | - | Stock option (right to buy) | |
| J. Kolean Chad | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 42,554 | 42,578 (0%) | 0% | 0 | Common Stock | |
| Kolean Chad J. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 104,000 | 104,000 | - | - | Stock option (right to buy) | |
| Shane Darrell Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 39,599 | 39,599 (0%) | 0% | 0 | Common Stock | |
| Caruso V. James | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 261,000 | 261,000 | - | - | Stock option (right to buy) | |
| Caruso V. James | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 40,596 | 49,236 (0%) | 0% | 0 | Common Stock | |
| Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 42,927 | 53,141 (0%) | 0% | 0 | Common Stock | |
| Andrei Shustov | Senior Vice President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 261,000 | 261,000 | - | - | Stock option (right to buy) | |
| Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 104,000 | 104,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 144,000 | 144,000 | - | - | Stock option (right to buy) | |
| Darrell Shane Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 11,700 | 11,700 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) | |
| Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) | |
| Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Dov Elefant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 422,000 | 422,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 1,419,000 | 1,419,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 475,000 | 475,000 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 14 Sep 2021 | 25,000 | 25,000 (0%) | 0% | 1.0 | 26,000 | Common Stock |
| Frederick W. Driscoll | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 03 Sep 2021 | 19,417 | 19,417 (0%) | 0% | 1.0 | 20,244 | Common Stock |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 78,000 | 78,000 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 117,000 | 117,000 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 78,000 | 78,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 78,000 | 78,000 | - | - | Stock option (right to buy) | |
| Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 78,000 | 78,000 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Mar 2021 | 58,640 | 23,232 | - | - | Series A Warrants | |
| John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Mar 2021 | 23,232 | 0 | - | - | Series A Warrants | |
| John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Mar 2021 | 41,155 | 193,587 | - | - | Series A Warrants | |
| John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Mar 2021 | 100,515 | 81,872 | - | - | Series A Warrants | |
| John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Mar 2021 | 11,200 | 182,387 | - | - | Series A Warrants | |
| Dov Elefant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 430,000 | 430,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Mar 2021 | 46,948 | 0 | - | - | Series A Warrants | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 1,600,000 | 1,600,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 04 Mar 2021 | 5,100 | 86,401 (0%) | 0% | 1.7 | 8,659 | Common Stock |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 450,000 | 450,000 | - | - | Stock option (right to buy) | |
| John E. Friend | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 330,000 | 330,000 | - | - | Stock option (right to buy) | |
| Dov Elefant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 28 Dec 2020 | 7,407 | 11,755 (0%) | 0% | 1.3 | 9,999 | Common Stock |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 28 Dec 2020 | 37,037 | 81,301 (0%) | 0% | 1.4 | 50,000 | Common Stock |
| Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 28 Dec 2020 | 29,630 | 102,148 (1%) | 0% | 1.4 | 40,001 | Common Stock |
| John E. Friend | VP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 80,000 | 80,000 | - | - | Stock option (right to buy) | |
| John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Stephen A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Dov Elefant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Jun 2020 | 2,174 | 2,174 | - | - | Series H Warrants | |
| Dov Elefant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 05 Jun 2020 | 4,348 | 4,348 (0%) | 0% | 1.1 | 4,978 | Common Stock |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 05 Jun 2020 | 21,740 | 44,264 (0%) | 0% | 1.1 | 24,892 | Common Stock |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Jun 2020 | 10,870 | 10,870 | - | - | Series H Warrants | |
| Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 05 Jun 2020 | 65,218 | 72,518 (0%) | 0% | 1.1 | 74,675 | Common Stock |
| Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Jun 2020 | 32,609 | 32,609 | - | - | Series H Warrants | |
| Stephen A. Hill | Director | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 04 Jun 2020 | 18,000 | 18,000 (0%) | 0% | 1.1 | 19,438 | Common Stock |
| Dov Elefant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2020 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2020 | 40,000 | 40,000 | - | - | Stock option (right to buy) | |
| Igor Grachev | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Dov Elefant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2019 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 6,500 | 6,500 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 9,750 | 9,750 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 6,500 | 6,500 | - | - | Stock option (right to buy) | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 6,500 | 6,500 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 6,500 | 6,500 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 28 Feb 2019 | 100 | 7,300 (0%) | 0% | 2 | 200 | Common Stock |
| Brian M. Posner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 75,000 | 75,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 30 Nov 2018 | 1,000 | 22,354 (0%) | 0% | 2.3 | 2,282 | Common Stock, par value $0.00001 per share |
| Stephen A. Hill | None | Sale of securities on an exchange or to another person at price $ 2.21 per share. | 29 Nov 2018 | 53 | 0 (0%) | 0% | 2.2 | 117 | Common Stock |
| Stephen A. Hill | None | Sale of securities on an exchange or to another person at price $ 2.21 per share. | 29 Nov 2018 | 939 | 53 (0%) | 0% | 2.2 | 2,075 | Common Stock |
| Stephen A. Hill | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Nov 2018 | 9,390 | 0 | - | - | Series A Warrants | |
| Stephen A. Hill | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Nov 2018 | 530 | 0 | - | - | Warrants | |
| Brian M. Posner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 54,000 | 54,000 | - | - | Stock option (right to buy) | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 13,000 | 13,000 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 13,000 | 13,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 13,000 | 13,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 13,000 | 13,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 63,000 | 63,000 | - | - | Stock option (right to buy) | |
| John E. Friend | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 63,000 | 63,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 16 Aug 2018 | 500 | 7,200 (0%) | 0% | 2.7 | 1,355 | Common Stock |
| Brian M. Posner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 80,000 | 80,000 | - | - | Stock option (right to buy) | |
| Jarrod Longcor | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 13 Mar 2018 | 13,000 | 67,000 (0%) | 0% | 1.2 | 15,397 | Common Stock |
| James V. Caruso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 12 Mar 2018 | 34,000 | 213,548 (1%) | 0% | 1.2 | 40,705 | Common Stock |
| John P. Neis | None | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 14 Nov 2017 | 5,214 | 626,103 (3%) | 0% | 1.5 | 7,791 | Common Stock, par value $0.00001 per share |
| Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2017 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2017 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Douglas J. Swirsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2017 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2017 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2017 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2017 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2017 | 200,000 | 247,548 (1%) | 1% | 0 | Common stock | |
| Chad J. Kolean | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2017 | 80,000 | 80,000 (0%) | 0% | 0 | Common stock | |
| Jarrod Longcor | Sr. VP of Corp Dev & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2017 | 80,000 | 80,000 (0%) | 0% | 0 | Common stock | |
| John E. Friend | VP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2017 | 100,000 | 100,000 (0%) | 0% | 0 | Common stock | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Nov 2016 | 333,333 | 607,946 | - | - | Series C Warrants (right to buy) | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Nov 2016 | 333,333 | 631,317 | - | - | Common Stock, par value $0.00001 per share | |
| Jarrod Longcor | Sr. VP of Corp Dev & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2016 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2016 | 22,500 | 25,434 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2016 | 22,500 | 24,750 | - | - | Stock option (right to buy) | |
| Stefan D. Loren | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2016 | 22,500 | 23,500 | - | - | Stock option (right to buy) | |
| James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2016 | 200,000 | 237,500 | - | - | Stock option (right to buy) | |
| Jamey P. Weichert | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2016 | 40,000 | 42,895 | - | - | Stock option (right to buy) | |
| Chad J. Kolean | VP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2016 | 50,000 | 52,000 | - | - | Stock option (right to buy) | |
| Stephen A. Hill | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 9,390 | 9,920 | - | - | Common Stock, par value $0.00001 per share | |
| Stephen A. Hill | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 9,390 | 9,920 | - | - | Series A Warrants | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 234,742 | 297,984 | - | - | Common Stock, par value $0.00001 per share | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 234,742 | 274,613 | - | - | Series A Warrants | |
| Paul L. Berns | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 117,371 | 117,371 | - | - | Series A Warrants | |
| Paul L. Berns | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 117,371 | 117,371 | - | - | Common Stock, par value $0.00001 per share | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 46,948 | 46,948 | - | - | Series A Warrants | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2016 | 46,948 | 47,548 | - | - | Common Stock, par value $0.00001 per share | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Nov 2015 | 1,000 | 6,000 | - | - | Common Stock, par value $0.00001 per share | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Nov 2015 | 1,000 | 5,000 | - | - | Common Stock, par value $0.00001 per share | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2015 | 2,000 | 2,000 | - | - | Common Stock, par value $0.00001 per share | |
| James V. Caruso | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2015 | 2,000 | 4,000 | - | - | Common Stock, par value $0.00001 per share | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2015 | 5,000 | 5,000 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2015 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Paul L. Berns | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2015 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Stephen A. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 5,500 | 5,500 | - | - | Stock option (right to buy) | |
| John P. Neis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Paul L. Berns | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| J. Patrick Genn | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Cameron Szakacs | VP of Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2014 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Marxe W Austin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Sep 2014 | 182 | 1,142,368 | - | - | Common Stock | |
| J. Patrick Genn | VP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2014 | 3,000 | 30,083 | - | - | Stock purchase warrant (right to buy) | |
| J. Patrick Genn | VP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2014 | 22,000 | 52,083 | - | - | Stock purchase warrant (right to buy) | |
| J. Patrick Genn | VP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2014 | 10,000 | 77,083 | - | - | Stock purchase warrant (right to buy) | |
| J. Patrick Genn | VP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Aug 2014 | 15,000 | 67,083 | - | - | Stock purchase warrant (right to buy) | |
| Stephen A. Hill | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 5,300 | 21,351 | - | - | Stock purchase warrant (right to buy) | |
| Stephen A. Hill | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 5,300 | 5,300 | - | - | Common Stock, par value $0.00001 per share | |
| John P. Neis | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 Aug 2014 | 50,000 | 0 | - | - | Convertible Debenture (right to buy) | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 138,711 | 268,711 | - | - | Stock Purchase Warrant (right to buy) | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 130,000 | 130,000 | - | - | Stock Purchase Warrant (right to buy) | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 130,000 | 493,715 | - | - | Common Stock, par value $0.00001 per share | |
| John P. Neis | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 138,711 | 632,426 | - | - | Common Stock, par value $0.00001 per share | |
| Simon Pedder | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 13,300 | 13,300 | - | - | Common Stock, par value $0.00001 per share | |
| Simon Pedder | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2014 | 13,300 | 277,578 | - | - | Stock purchase warrant (right to buy) | |
| Marxe W Austin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2014 | 65,687 | 1,136,487 | - | - | Common Stock | |
| Marxe W Austin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2014 | 4,800 | 1,070,800 | - | - | Common Stock | |
| Marxe W Austin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2014 | 5,699 | 1,142,186 | - | - | Common Stock |